QuidelOrtho Corporation (QDEL) Key Metrics
QDEL valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $885.3M
- Enterprise value
- $3.66B
- P/E (TTM)
- — 10-yr median 9.7
- Forward P/E
- 9.6
- PEG ratio
- 2.06
- Price / sales
- 0.3 10-yr median 3.5
- Price / book
- 0.4 10-yr median 3.2
- EV / EBITDA
- 22.8 10-yr median 14.1
- Dividend yield
- —
- Beta
- 0.78
QDEL key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsQDEL valuation Price multiples at each fiscal year-end price.
QDEL returns How much profit the business earns on the capital it uses.
QDEL per-share figures Results divided by the shares outstanding at year-end.
QDEL financial health Debt, liquidity and how easily interest is covered.
QDEL efficiency & capital use Working capital cycle and where the cash goes.
QDEL valuation history
QDEL returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
QDEL debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
QDEL cash returned to shareholders
QDEL price vs earnings per share
QDEL key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $1.94B | $2.99B | $4.92B | $4.92B | $5.79B | $7.83B | $3.23B | $2.08B | $1.46B | $700.6M |
| Enterprise value | $4.57B | $5.58B | $7.37B | $7.42B | $5.10B | $7.45B | $3.29B | $2.14B | $1.82B | $679.5M |
| P/E ratio | — | — | — | 9.0 | 8.2 | 9.7 | 44.4 | 28.0 | — | — |
| Price / sales | 0.7 | 1.1 | 1.6 | 1.5 | 3.4 | 4.7 | 6.0 | 4.0 | 5.3 | 3.7 |
| Price / book | 1.0 | 1.0 | 1.0 | 1.0 | 3.0 | 5.9 | 5.8 | 4.9 | 6.4 | 3.5 |
| Price / free cash flow | — | — | 69.4 | 6.6 | 11.3 | 13.9 | 30.2 | 19.9 | 143.4 | — |
| Price / operating cash flow | 18.4 | 36.1 | 17.6 | 5.6 | 7.2 | 12.4 | 24.1 | 15.2 | 52.8 | 59.3 |
| EV / sales | 1.7 | 2.0 | 2.5 | 2.3 | 3.0 | 4.5 | 6.2 | 4.1 | 6.6 | 3.5 |
| EV / EBITDA | — | — | 12.1 | 6.8 | 5.3 | 6.8 | 23.6 | 16.0 | 45.2 | 36.2 |
| EV / free cash flow | — | — | 103.9 | 10.0 | 9.9 | 13.2 | 30.7 | 20.5 | 178.8 | — |
| Earnings yield | −58.4% | −68.5% | −0.2% | 11.2% | 12.2% | 10.3% | 2.3% | 3.6% | −0.6% | −2.0% |
| Free cash flow yield | −4.3% | −3.7% | 1.4% | 15.1% | 8.9% | 7.2% | 3.3% | 5.0% | 0.7% | −0.0% |
| Dividend yield | — | — | — | — | — | — | — | — | 17.4% | 0.0% |
| Shareholder yield (dividends + buybacks) | 0.0% | 0.3% | 0.1% | 1.5% | 1.8% | 0.6% | 0.3% | 0.2% | 17.5% | 2.9% |
| Share price at fiscal year-end | $28.56 | $44.55 | $73.70 | $85.67 | $134.99 | $179.65 | $75.03 | $48.82 | $43.35 | $21.42 |
| Per share | ||||||||||
| Revenue per share | $40.27 | $41.41 | $44.88 | $56.90 | $39.62 | $38.12 | $12.41 | $12.27 | $8.23 | $5.86 |
| Earnings per share | −$16.69 | −$30.54 | −$0.15 | $9.56 | $16.42 | $18.59 | $1.69 | $1.74 | −$0.24 | −$0.42 |
| Operating cash flow per share | $1.55 | $1.24 | $4.19 | $15.42 | $18.80 | $14.45 | $3.12 | $3.20 | $0.82 | $0.36 |
| Free cash flow per share | −$1.22 | −$1.67 | $1.06 | $12.97 | $11.97 | $12.96 | $2.49 | $2.46 | $0.30 | −$0.00 |
| Cash per share | $2.98 | $1.46 | $2.50 | $6.01 | $19.32 | $11.24 | $1.22 | $1.03 | $1.07 | $5.18 |
| Book value per share | $28.33 | $44.41 | $74.94 | $85.97 | $45.00 | $30.57 | $12.99 | $10.00 | $6.73 | $6.13 |
| Tangible book value per share | −$9.49 | −$5.96 | −$6.29 | −$11.60 | $34.84 | $20.03 | $1.73 | −$2.03 | −$9.30 | $2.73 |
| Dividends per share | — | — | — | — | — | — | — | — | $7.56 | $0.00 |
| Capex per share | $2.78 | $2.90 | $3.13 | $2.45 | $6.83 | $1.49 | $0.63 | $0.74 | $0.52 | $0.36 |
| Debt per share | $41.80 | $39.90 | $39.13 | $49.64 | $3.25 | $2.49 | $2.60 | $2.53 | $11.78 | $4.54 |
| Shares outstanding | 67.8M | 67.2M | 66.8M | 57.4M | 42.9M | 43.6M | 43.1M | 42.6M | 33.7M | 32.7M |
| Change in shares outstanding | +0.9% | +0.6% | +16.4% | +33.9% | −1.6% | +1.1% | +1.3% | +26.1% | +3.1% | −4.1% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −46.1% | −51.4% | −0.2% | 16.0% | 43.2% | 85.6% | 14.8% | 22.7% | −3.8% | −6.6% |
| Return on invested capital (ROIC) | −14.4% | −23.8% | 1.5% | 14.5% | 64.7% | 105.2% | 15.8% | 17.8% | 2.0% | −2.0% |
| Return on assets (ROA) | −18.6% | −27.4% | −0.1% | 9.7% | 32.7% | 58.3% | 8.5% | 8.5% | −1.2% | −3.5% |
| Return on tangible assets | −35.3% | −67.5% | −0.3% | 16.9% | 35.3% | 57.4% | 17.1% | 25.2% | −2.1% | −5.0% |
| Free cash flow margin | −3.0% | −4.0% | 2.4% | 22.8% | 30.2% | 34.0% | 20.1% | 20.0% | 3.7% | −0.0% |
| Income quality (OCF / net income) | — | — | — | 1.61 | 1.14 | 0.78 | 1.84 | 1.84 | — | — |
| Financial health | ||||||||||
| Total debt | $2.83B | $2.68B | $2.61B | $2.85B | $139.3M | $108.5M | $112.3M | $107.6M | $397.4M | $148.4M |
| Cash & short-term investments | $202.2M | $98.3M | $167.3M | $345.0M | $828.5M | $489.9M | $52.8M | $43.7M | $36.1M | $169.5M |
| Net debt | $2.63B | $2.58B | $2.45B | $2.50B | −$689.2M | −$381.4M | $59.5M | $63.9M | $361.4M | −$21.1M |
| Debt / equity | 1.48 | 0.90 | 0.52 | 0.58 | 0.07 | 0.08 | 0.20 | 0.25 | 1.75 | 0.74 |
| Debt / assets | 0.49 | 0.42 | 0.31 | 0.32 | 0.06 | 0.06 | 0.12 | 0.13 | 0.42 | 0.38 |
| Net debt / EBITDA | — | — | 4.03 | 2.29 | −0.72 | −0.35 | 0.43 | 0.48 | 8.96 | −1.12 |
| Current ratio | 1.50 | 1.22 | 1.57 | 1.56 | 4.45 | 3.39 | 1.77 | 1.21 | 2.58 | 6.71 |
| Quick ratio | 0.90 | 0.69 | 0.88 | 1.04 | 3.84 | 3.05 | 1.30 | 0.79 | 2.06 | 5.93 |
| Interest coverage | -5.2 | -10.4 | 0.8 | 11.3 | — | 839.5 | 6.3 | 4.0 | 0.5 | -0.4 |
| Working capital | $481.2M | $220.1M | $476.7M | $568.1M | $1.12B | $805.4M | $96.3M | $33.7M | $202.9M | $191.8M |
| Invested capital | $4.55B | $5.57B | $7.45B | $7.44B | $1.24B | $951.3M | $619.3M | $489.5M | $588.5M | $179.5M |
| Tangible asset value | −$643.3M | −$400.6M | −$420.4M | −$666.0M | $1.49B | $873.2M | $74.7M | −$86.5M | −$313.8M | $89.2M |
| Net current asset value | −$2.40B | −$2.22B | −$2.25B | −$2.35B | $939.3M | $603.9M | −$128.8M | −$187.4M | −$376.9M | $37.8M |
| Graham number | — | — | — | $135.98 | $128.96 | $113.08 | $22.23 | $19.81 | — | — |
| Graham net-net per share | −$44.91 | −$40.71 | −$40.94 | −$50.08 | $16.85 | $9.30 | −$4.46 | −$5.77 | −$17.19 | $0.42 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | — | — | — | — | — | $255.0M | $0 |
| Share buybacks (net) | $0 | $9.6M | $7.2M | $74.3M | $103.4M | $43.7M | $10.7M | $4.3M | $541,000 | $20.2M |
| Dividends + buybacks / free cash flow | — | — | 10.2% | 10.0% | 20.2% | 7.7% | 10.0% | 4.2% | — | — |
| Capex / revenue | 6.9% | 7.0% | 7.0% | 4.3% | 17.2% | 3.9% | 5.1% | 6.1% | 6.3% | 6.2% |
| Capex / operating cash flow | 178.9% | 235.1% | 74.7% | 15.9% | 36.3% | 10.3% | 20.2% | 23.2% | 63.2% | 100.8% |
| Capex / depreciation | 0.43 | 0.43 | 0.46 | 0.50 | 5.55 | 1.32 | 0.57 | 0.68 | 0.57 | 0.52 |
| Stock-based compensation / revenue | 1.7% | 1.5% | 1.7% | 1.5% | 1.5% | 1.3% | 2.5% | 2.2% | 3.3% | 4.2% |
| R&D / revenue | 6.8% | 7.9% | 8.2% | 5.8% | 5.6% | 5.1% | 9.8% | 9.9% | 12.1% | 20.2% |
| SG&A / revenue | 27.3% | 27.6% | 25.5% | 19.0% | 14.1% | 12.1% | 30.6% | 29.5% | 34.7% | 39.1% |
| Efficiency | ||||||||||
| Days sales outstanding | 58.0 | 61.6 | 65.4 | 54.8 | 99.2 | 69.4 | 61.2 | 54.2 | 67.9 | 41.3 |
| Days of inventory on hand | 139.3 | 135.6 | 134.0 | 99.2 | 135.7 | 100.3 | 107.0 | 118.8 | 139.8 | 130.3 |
| Days payables outstanding | 65.9 | 66.0 | 70.3 | 52.8 | 81.6 | 65.9 | 44.2 | 46.3 | 65.0 | 61.5 |
| Cash conversion cycle (days) | 131.5 | 131.2 | 129.1 | 101.2 | 153.3 | 103.7 | 123.9 | 126.7 | 142.6 | 110.2 |
| Receivables turnover | 6.29 | 5.92 | 5.58 | 6.66 | 3.68 | 5.26 | 5.97 | 6.73 | 5.37 | 8.83 |
| Payables turnover | 5.54 | 5.53 | 5.19 | 6.91 | 4.48 | 5.54 | 8.25 | 7.88 | 5.61 | 5.94 |
| Inventory turnover | 2.62 | 2.69 | 2.72 | 3.68 | 2.69 | 3.64 | 3.41 | 3.07 | 2.61 | 2.80 |
| Asset turnover | 0.45 | 0.37 | 0.34 | 0.58 | 0.79 | 1.19 | 0.62 | 0.60 | 0.42 | 0.48 |
| Average receivables | $434.1M | $469.9M | $537.4M | $490.1M | $461.5M | $315.8M | $89.6M | $77.6M | $51.7M | $21.7M |
| Average payables | $262.7M | $270.4M | $289.1M | $192.4M | $93.9M | $56.5M | $25.9M | $26.2M | $21.7M | $12.4M |
| Average inventory | $555.6M | $555.8M | $551.0M | $361.4M | $156.3M | $85.9M | $62.7M | $67.2M | $46.6M | $26.2M |
| Intangibles / total assets | 44.4% | 52.7% | 63.4% | 63.2% | 17.9% | 24.6% | 53.3% | 63.5% | 57.8% | 28.7% |
Computed from QDEL's annual financial statements (latest annual report filed February 19, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
QDEL valuation and financial ratios
QuidelOrtho earned a return on equity of −46.1% and a return on invested capital of −14.4% in fiscal 2025. It ended the year with $2.8 billion of debt and $202.2 million in cash and short-term investments, net debt of $2.6 billion. The share count rose 107.3% from 32.7M to 67.8M over 9 years.
See the QDEL income statement, the QDEL chart for price history, or the QDEL stock overview for the latest quote and news.
QDEL key metrics FAQ
What is QuidelOrtho's return on equity?
QuidelOrtho's return on equity (ROE) was −46.1% in fiscal 2025: net income of -$1.1 billion on average shareholders' equity of $2.5 billion.
What is QuidelOrtho's ROIC?
QuidelOrtho's return on invested capital was −14.4% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does QuidelOrtho have?
QuidelOrtho had total debt of $2.8 billion at the end of fiscal 2025, a debt-to-equity ratio of 1.48.
What is QuidelOrtho's free cash flow yield?
QuidelOrtho generated -$83.0 million of free cash flow in fiscal 2025, a free cash flow yield of −4.3% on its market value at year-end ($1.9 billion).
What is QuidelOrtho's current ratio?
QuidelOrtho's current ratio was 1.50 at the end of fiscal 2025: current assets were 1.50 times current liabilities.